Best CellCarta Alternatives ranked by AI · updated Aug 2026

CellCarta provides biomarker, spatial biology, proteomics, genomics, and immune-monitoring services for biopharmaceutical research and clinical development. It is aimed at sponsors developing precision medicine programs that require advanced analysis of tissue, blood, and single cells.

Developer: CellCarta Price: N/A 🎯 cellcarta.com

Top 6 CellCarta alternatives

NeoGenomics Pharma Services provides central laboratory, anatomic pathology, biomarker, and specialty testing support for biopharmaceutical clinical trials. It is designed for pharmaceutical...

Pros

  • Strong oncology pathology and biomarker expertise
  • Offers central lab, specialty testing, and tissue-based services through one provider
  • Well suited to trials requiring immunohistochemistry, molecular testing, or digital pathology

Cons

  • More specialized toward oncology than broad full-service CROs
  • Public pricing and standardized package details are limited
  • May provide fewer end-to-end clinical operations services than large CROs
2

Labcorp

Laboratory Corporation of America Holdings

Labcorp provides clinical laboratory testing, pathology, genetic testing, and drug-development services for patients, providers, employers, and insurers. Its patient services include nationwide...

Pros

  • Comparable nationwide alternative with a broad routine-testing menu
  • Strong integration with provider orders and electronic results
  • Offers consumer-accessible testing for selected services

Cons

  • Coverage and appointment availability vary by location
  • Self-pay prices may be unclear until test and billing details are selected
  • Some tests require a clinician order

Varies by test, location, and insurance

3

Q2 Solutions

IQVIA

Q2 Solutions provides central laboratory, genomic, biomarker, and companion diagnostic services for biopharmaceutical clinical trials. It serves sponsors and CROs globally, with...

Pros

  • Broader global central-lab network than NeoGenomics
  • Strong genomics, biomarker, and companion diagnostic capabilities
  • Integrates laboratory services with IQVIA clinical development infrastructure

Cons

  • May be less oncology-specialized than NeoGenomics
  • Large-provider processes can be less flexible for smaller studies
  • Typically requires a custom commercial proposal
4

ICON

ICON plc

ICON is a global contract research organization providing clinical development, laboratory, biomarker, and related pharmaceutical services. It serves biotechnology and pharmaceutical sponsors...

Pros

  • Provides broader end-to-end CRO support than NeoGenomics
  • Global operational footprint across phases and therapeutic areas
  • Can coordinate clinical operations, biomarker work, and data services

Cons

  • Laboratory and pathology work is less central to its identity than at NeoGenomics
  • May be less nimble for focused oncology testing projects
  • Broader CRO engagements can increase complexity and cost
5

Medpace

Medpace

Medpace is a global contract research organization offering clinical development, central laboratory, biomarker, and regulatory services. It primarily supports biotechnology and pharmaceutical...

Pros

  • Combines central laboratory capabilities with full-service clinical operations
  • Strong experience supporting biotechnology sponsors
  • Integrated regulatory, medical, and data management services

Cons

  • Less specialized in oncology pathology than NeoGenomics
  • Not the best fit when only tissue testing or biomarker analysis is needed
  • Full-service engagement may be heavier than a central-lab contract
6

LabConnect

LabConnect

LabConnect provides central laboratory, specialty testing, biomarker, sample management, and laboratory project management services for clinical trials. It works with pharmaceutical, biotechnology,...

Pros

  • Focused laboratory specialist rather than a broad CRO
  • Flexible central-lab and specialty-testing support
  • Provides sample logistics, laboratory project management, and data services

Cons

  • Less oncology-specific pathology depth than NeoGenomics
  • Smaller global footprint than the largest CRO-owned laboratories
  • Does not provide the same breadth of clinical operations as full-service CROs

How good are these alternatives?

Your feedback helps us improve the AI rankings.

βœ… Thanks for your feedback!

Know a better alternative? πŸ™Œ

Suggest a product and our AI will verify it's a real alternative to CellCarta before adding it to the list.